LakeShore Biopharma Co., Ltd Net Asset Quality Index
LakeShore Biopharma Co., Ltd net asset quality index. LakeShore Biopharma Co., Ltd (LSBCF) has a Net Asset Quality Index of 36.5% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.37 Billion minus total liabilities of $867.91 Million yields net assets of $499.75 Million. A higher index indicates a stronger, lower-leverage balance sheet. See LSBCF book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of LakeShore Biopharma Co., Ltd (2021–2025)
Net asset quality index of LakeShore Biopharma Co., Ltd from 2021 to 2025. This chart shows how LakeShore Biopharma Co., Ltd's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of June 2025, the index stands at 36.5%, representing net assets of $499.75 Million against total assets of $1.37 Billion USD. Check tangible net worth ratio of LakeShore Biopharma Co., Ltd to evaluate the tangible quality of the company's equity base.
LakeShore Biopharma Co., Ltd Net Asset Quality Index by Year (2021–2025)
LakeShore Biopharma Co., Ltd net asset quality index by year from 2021 to 2025. The table below presents the year-by-year Net Asset Quality Index for LakeShore Biopharma Co., Ltd from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see LakeShore Biopharma Co., Ltd (LSBCF) market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 36.5% | $499.75 Million | $1.37 Billion | $867.91 Million | ▼ -2.1 pp |
| 2024 | 38.7% | $585.21 Million | $1.51 Billion | $927.82 Million | ▼ -3.7 pp |
| 2023 | 42.4% | $728.45 Million | $1.72 Billion | $991.30 Million | ▼ -47.5 pp |
| 2022 | 89.9% | $180.68 Million | $201.03 Million | $20.35 Million | ▲ +66.5 pp |
| 2021 | 23.4% | $21.36K | $91.37K | $70.01K | — |